RankingsPricing
  1. JP-listed companies
  2. HISAMITSU PHARMACEUTICAL CO.,INC.
  3. Financials
  4. D/E ratio (%)

HISAMITSU PHARMACEUTICAL CO.,INC.【JP:4530】

Market cap
¥548.5B
P/E ratio
21.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndD/E ratio (%) (Million JPY)YoY (%)
Feb 28, 20251+129.93%
Feb 29, 20240.4-8.89%
Feb 28, 20230.5-6.87%
Feb 28, 20220.5-8.70%
Feb 28, 20210.6-11.86%
Feb 29, 20200.6-13.00%
Feb 28, 20190.7-9.78%
Feb 28, 20180.8-14.06%
Feb 28, 20170.9-9.53%
Feb 29, 20161-5.13%
Feb 28, 20151.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)